Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell arteritis (GCA), a debilitating autoimmune disease affecting the arteries. In the ...
Global Demand for Precision Orthopedic Devices Surges as the Drill Surgical Power Tool Market, Valued at USD 2.3 Billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback